Clinical Trial Update: Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Leg After a Stroke [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial by Merz Pharma evaluating botulinum toxin type A versus placebo for lower-limb spasticity after stroke; results were completed and po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-stroke Spasticity
• Stroke

Drugs mentioned

• XEOMIN (INCOBOTULINUMTOXINA)

Snippet

Sponsor: Merz Pharmaceuticals GmbH | Conditions: Post-stroke Spasticity of the Lower Limb | Phase 3 | Status: COMPLETED | Results posted: 2016-11-07